Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sevoflurane's Effect on Neurocognition Study

NCT: NCT06044740 · COMPLETED

NCT IDNCT06044740
StatusCOMPLETED
Start Date2024-01-17
Completion2026-01-30

Brief Summary

The purpose of this study is to determine the effects of acute pain on long-term memory and conditioned physiologic responses in the presence and absence of low dose sevoflurane. Functional magnetic resonance imaging will be used to identify the neural correlates of these phenomena. The study will occur over 2 visits and involves no long-term follow up.

Frequently Asked Questions

What is Sevoflurane's Effect on Neurocognition Study?

Sevoflurane's Effect on Neurocognition Study is a clinical trial registered under NCT06044740. Current status: COMPLETED.

What is the status of NCT06044740?

The current status of NCT06044740 (Sevoflurane's Effect on Neurocognition Study) is: COMPLETED.

When did Sevoflurane's Effect on Neurocognition Study start?

Sevoflurane's Effect on Neurocognition Study started on 2024-01-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.